# Anixa Biosciences Inc: filings

ANIX · Nasdaq · CIK 715446 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Oct 31

Pages: [Overview](/companies/anix.md) · [Financials](/companies/anix/financials.md) · [Filings](/companies/anix/filings.md) · [Insiders](/companies/anix/insiders.md)

## Reports and events: 234 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 387, 8-K 101, 10-Q 54, CORRESP 23, UPLOAD 21, DEF 14A 19, 10-K 18, 3 18, EFFECT 13, S-8 13, SC 13D/A 12, DEFA14A 11, SC 13D 9, S-3 8, 10-K/A 7, 424B5 7, 10-Q/A 6, CT ORDER 6, PRE 14A 6, S-3/A 6, 424B3 5, 5 5, D 5, POS AM 4, 424B2 3, 4/A 3, S-1 3, SC 13G 3, SC 13G/A 3, SCHEDULE 13D/A 3, 3/A 2, AW 2, FWP 2, NT 10-K 2, S-1/A 2, 144 1, 8-A12B 1, ARS 1, CERTNAS 1, DEL AM 1, DFAN14A 1, NT 10-Q 1, PREC14A 1, PRER14A 1, RW 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-09 | 16:15 ET | [10-Q](/filings/0001493152-26-041963.md) | Quarterly report, period 2026-07-31 | 0001493152-26-041963 |
| 2026-06-10 | 16:15 ET | [10-Q](/filings/0001493152-26-028105.md) | Quarterly report, period 2026-04-30 | 0001493152-26-028105 |
| 2026-03-11 | 17:03 ET | [8-K](/filings/0001493152-26-009699.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-009699 |
| 2026-03-09 | 16:16 ET | [10-Q](/filings/0001493152-26-009370.md) | Quarterly report, period 2026-01-31 | 0001493152-26-009370 |
| 2026-02-09 | 08:02 ET | [8-K](/filings/0001493152-26-005702.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-005702 |
| 2026-01-28 | 16:16 ET | [DEF 14A](/filings/0001493152-26-004035.md) | Proxy statement, period 2026-01-28 | 0001493152-26-004035 |
| 2026-01-12 | 16:01 ET | [10-K](/filings/0001493152-26-001845.md) | Annual report, period 2025-10-31 | 0001493152-26-001845 |
| 2026-01-06 | 19:48 ET | [SCHEDULE 13D/A](/filings/0001493152-26-000691.md) | Ownership report, active investor, amended | 0001493152-26-000691 |
| 2025-12-12 | 18:34 ET | [8-K](/filings/0001493152-25-027321.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-027321 |
| 2025-09-10 | 16:30 ET | [10-Q](/filings/0001493152-25-013000.md) | Quarterly report, period 2025-07-31 | 0001493152-25-013000 |
| 2025-06-06 | 17:36 ET | [SCHEDULE 13D/A](/filings/0001641172-25-014126.md) | Ownership report, active investor, amended | 0001641172-25-014126 |
| 2025-05-28 | 16:20 ET | [10-Q](/filings/0001641172-25-012701.md) | Quarterly report, period 2025-04-30 | 0001641172-25-012701 |
| 2025-03-21 | 16:15 ET | [8-K](/filings/0001493152-25-011151.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-011151 |
| 2025-03-11 | 16:20 ET | [10-Q](/filings/0001493152-25-009854.md) | Quarterly report, period 2025-01-31 | 0001493152-25-009854 |
| 2025-02-06 | 16:15 ET | [DEF 14A](/filings/0001493152-25-005199.md) | Proxy statement, period 2024-10-31 | 0001493152-25-005199 |
| 2025-01-10 | 17:18 ET | [10-K](/filings/0001493152-25-001787.md) | Annual report, period 2024-10-31 | 0001493152-25-001787 |
| 2025-01-03 | 18:26 ET | [SCHEDULE 13D/A](/filings/0001493152-25-000323.md) | Ownership report, active investor, amended | 0001493152-25-000323 |
| 2024-11-08 | 13:31 ET | [8-K](/filings/0001493152-24-044224.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-044224 |
| 2024-09-06 | 17:00 ET | [10-Q](/filings/0001493152-24-035335.md) | Quarterly report, period 2024-07-31 | 0001493152-24-035335 |
| 2024-06-04 | 17:00 ET | [10-Q](/filings/0001493152-24-022573.md) | Quarterly report, period 2024-04-30 | 0001493152-24-022573 |
| 2024-05-08 | 08:35 ET | [8-K](/filings/0001493152-24-018170.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-018170 |
| 2024-05-03 | 13:31 ET | [SC 13D](/filings/0001493152-24-017664.md) | Ownership report, active investor | 0001493152-24-017664 |
| 2024-03-22 | 16:30 ET | [8-K](/filings/0001493152-24-010995.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-010995 |
| 2024-03-12 | 17:00 ET | [10-Q](/filings/0001493152-24-009683.md) | Quarterly report, period 2024-01-31 | 0001493152-24-009683 |
| 2024-02-08 | 16:15 ET | [DEF 14A](/filings/0001493152-24-005470.md) | Proxy statement, period 2024-02-08 | 0001493152-24-005470 |
| 2024-01-16 | 17:29 ET | [SC 13D/A](/filings/0001493152-24-002508.md) | Ownership report, active investor, amended | 0001493152-24-002508 |
| 2024-01-16 | 16:30 ET | [10-K](/filings/0001493152-24-002453.md) | Annual report, period 2023-10-31 | 0001493152-24-002453 |
| 2023-12-07 | 06:01 ET | [8-K](/filings/0001493152-23-043932.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-043932 |
| 2023-09-06 | 16:15 ET | [10-Q](/filings/0001493152-23-031826.md) | Quarterly report, period 2023-07-31 | 0001493152-23-031826 |
| 2023-06-14 | 17:09 ET | [10-Q](/filings/0001493152-23-021271.md) | Quarterly report, period 2023-04-30 | 0001493152-23-021271 |
| 2023-04-17 | 13:45 ET | [8-K](/filings/0001493152-23-012483.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-012483 |
| 2023-03-17 | 21:29 ET | [10-Q](/filings/0001493152-23-007994.md) | Quarterly report, period 2023-01-31 | 0001493152-23-007994 |
| 2023-03-10 | 08:00 ET | [8-K](/filings/0001493152-23-007172.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-007172 |
| 2023-01-27 | 16:05 ET | [DEF 14A](/filings/0001493152-23-002760.md) | Proxy statement, period 2023-01-27 | 0001493152-23-002760 |
| 2023-01-04 | 16:59 ET | [10-K](/filings/0001493152-23-000346.md) | Annual report, period 2022-10-31 | 0001493152-23-000346 |
| 2022-12-08 | 08:40 ET | [8-K](/filings/0001493152-22-034828.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-034828 |
| 2022-09-29 | 08:30 ET | [8-K](/filings/0001493152-22-027121.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-027121 |
| 2022-09-09 | 16:15 ET | [10-Q](/filings/0001493152-22-025490.md) | Quarterly report, period 2022-07-31 | 0001493152-22-025490 |
| 2022-08-17 | 10:44 ET | [8-K](/filings/0001493152-22-023285.md) | 8.01 Other events | 0001493152-22-023285 |
| 2022-06-10 | 16:22 ET | [10-Q](/filings/0001493152-22-016452.md) | Quarterly report, period 2022-04-30 | 0001493152-22-016452 |
| 2022-04-15 | 09:52 ET | [8-K](/filings/0001493152-22-010016.md) | 5.02 Departure or appointment of officers or directors | 0001493152-22-010016 |
| 2022-03-11 | 16:25 ET | [8-K](/filings/0001493152-22-006637.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-006637 |
| 2022-03-11 | 16:05 ET | [10-Q](/filings/0001493152-22-006618.md) | Quarterly report, period 2022-01-31 | 0001493152-22-006618 |
| 2022-01-28 | 16:00 ET | [DEF 14A](/filings/0001493152-22-002541.md) | Proxy statement, period 2022-01-28 | 0001493152-22-002541 |
| 2022-01-04 | 16:06 ET | [10-K](/filings/0001493152-22-000302.md) | Annual report, period 2021-10-31 | 0001493152-22-000302 |
| 2021-12-09 | 16:15 ET | [8-K](/filings/0001493152-21-030965.md) | 5.08 Item not in the standard list | 0001493152-21-030965 |
| 2021-10-28 | 16:54 ET | [8-K](/filings/0001493152-21-026636.md) | 7.01 Regulation FD disclosure | 0001493152-21-026636 |
| 2021-10-04 | 07:00 ET | [8-K](/filings/0001493152-21-024422.md) | 8.01 Other events | 0001493152-21-024422 |
| 2021-09-03 | 16:15 ET | [SC 13D/A](/filings/0001493152-21-022017.md) | Ownership report, active investor, amended | 0001493152-21-022017 |
| 2021-09-01 | 16:46 ET | [10-Q](/filings/0001493152-21-021799.md) | Quarterly report, period 2021-07-31 | 0001493152-21-021799 |

Page 1 of 5. [Older](/companies/anix/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 16:16 ET. No prices; not investment advice.